Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
Associate PartnerAssociate Partner
LIVE TV DownloadNews18 App
News18 English
News18 » World
2-min read

Cows to Help Fight HIV? Antibodies May Hold the Clue to a Vaccine

The study, published in the journal ‘Nature’, theorises that cows evolved a supreme immune defence due to their complex and bacteria-packed digestive system. Thus giving hope for the development of a broadly effective AIDS vaccine in the near future.

News18.com

Updated:July 22, 2017, 9:59 AM IST
facebookTwitterskypewhatsapp
Cows to Help Fight HIV? Antibodies May Hold the Clue to a Vaccine
Photo for representation.

Washington: A team of researchers have found that the cows’ immune system can produce powerful, HIV-blocking antibodies within a matter of weeks, giving hope for the development of a broadly effective AIDS vaccine in the near future. The similar process in the human body would usually take years.

The study, published in the journal ‘Nature’, theorises that cows evolved a supreme immune defence due to their complex and bacteria-packed digestive system. "One approach to a preventive HIV vaccine involves trying to elicit broadly neutralising antibodies in healthy people, but so far the experiments have been unsuccessful, in both human and animal studies," said lead author Devin Sok, Director, Antibody Discovery and Development at the International AIDS Vaccine Initiative (IAVI).

"This experiment demonstrates that not only is it possible to produce these antibodies in animals, but we can do so reliably, quickly, and using a relatively simple immunisation strategy when given in the right setting," Sok added.

Scientists have known that some people living with chronic HIV infection produce broadly neutralising antibodies (bnAbs), which can overcome the high levels of diversity of HIV. One type of bnAb uses long, arm-like loops that are capable of reaching concealed areas on the virus's surface to block infection.

IANS reported that the scientists had a question: what would happen if they immunise cows with an HIV immunogen?

"The answer began with a single protein on HIV's surface that serves as a bnAb target – develop an antibody that recognises variants of this protein on different HIV viruses and you'll likely be protected from all of them," the study said.

One of the many tricks that HIV uses to prevent humans from developing the right antibodies is to display irrelevant forms of this protein to distract the immune system. Scientists thought they had overcome this challenge by developing an immunogen called "BG505 SOSIP", which closely mimics the protein target.

In the new study, four cows immunised with "BG505 SOSIP" elicited "bnAbs" to HIV within 35-52 days. In comparison, it takes HIV-positive humans multiple years to develop comparable responses, and only 5-15 per cent even develop them at all. "Cows cannot be infected with HIV, of course. But these findings illuminate a new goal for HIV vaccine researchers: by increasing the number of human antibodies with long loops, we might have an easier chance of eliciting protective bnAbs by vaccination," the researchers noted.

There is no doubt that cows' ability to produce bNAbs against a complicated pathogen like HIV in a matter of weeks, highlights even broader significance, particularly for emerging pathogens.

Sok is an affiliate of IAVI's Neutralising Antibody Center (NAC), a part of The Scripps Research Institute (TSRI) where multiple groups of scientists work collectively on an antibody-based HIV vaccine.

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

| Edited by: Aditya Nair
Read full article
Next Story
Next Story

Also Watch

facebookTwitterskypewhatsapp

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results